Cero Therapeutics Holdings reported total assets of $0.00B and total liabilities of $0.03B for the quarter ended Jun 2026, down 69.4% year over year. This balance sheet covers 19 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 1.10M | 0.55M | 0.48M | 0.18M | 0.11M | 0.12M | 1.60M | 4.59M | 3.65M | 3.38M | 3.33M | 5.20M | 3.30M | 2.02M | 1.66M | 0.86M | 0.94M | ||
| Short-term InvestmentsInvestments (Current) | 0.50M | ||||||||||||||||||
| Cash & Current Investments | 1.10M | 0.55M | 0.48M | 0.18M | 0.11M | 0.12M | 1.60M | 4.59M | 3.65M | 3.38M | 3.33M | 5.20M | 3.80M | 2.02M | 1.66M | 0.86M | 0.94M | ||
| Receivables - OtherOther Receivables | 0.16M | 0.09M | |||||||||||||||||
| Prepaid Assets | 0.26M | 0.31M | 0.29M | 0.28M | 0.23M | 0.22M | 0.11M | 0.02M | 0.37M | 0.75M | 0.51M | 0.33M | 0.27M | 0.56M | 0.44M | 0.53M | 1.07M | 0.72M | 0.61M |
| Current Assets | 1.36M | 1.10M | 0.85M | 0.79M | 42.37M | 1.97M | 5.50M | 4.25M | 3.71M | 3.71M | 5.77M | 4.25M | 2.55M | 2.73M | 1.57M | 1.55M | |||
| Non-Current Assets | |||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.97M | 0.85M | 0.74M | 0.62M | 0.53M | 0.45M | 0.38M | 0.31M | 0.25M | 0.18M | 0.13M | ||||||||
| Long-Term Investments | 178.50M | 178.53M | 178.79M | 179.64M | 41.67M | 0.10M | 0.15M | 0.02M | |||||||||||
| Other Non-Current Assets | 0.20M | 0.15M | 0.09M | 0.02M | 41.67M | 0.08M | 0.68M | 0.55M | 0.50M | 0.57M | 0.50M | 0.07M | 0.25M | 0.07M | 0.07M | 0.07M | |||
| Non-Current Assets | 178.72M | 178.68M | 178.88M | 179.67M | 3.16M | 3.55M | 3.12M | 2.78M | 2.49M | 2.22M | 1.96M | 1.36M | 0.91M | 0.63M | 0.35M | ||||
| Assets | 180.08M | 179.78M | 179.72M | 180.45M | 42.37M | 14.43M | 14.11M | 8.47M | 5.13M | 9.05M | 7.37M | 6.49M | 6.21M | 7.99M | 6.20M | 3.91M | 3.64M | 2.21M | 1.90M |
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Accounts Payables | 0.01M | 0.12M | 0.16M | 0.71M | 1.65M | 2.02M | 3.15M | 3.31M | 1.67M | 7.06M | 6.35M | 6.67M | 4.51M | 6.38M | 6.21M | 7.08M | 7.58M | 7.69M | 8.22M |
| Notes Payables | 0.65M | 0.65M | 1.18M | 1.40M | 0.60M | 0.40M | 0.25M | 0.10M | 0.75M | ||||||||||
| Dividends payables | 0.09M | 0.09M | 0.09M | 0.09M | |||||||||||||||
| Payables | 0.01M | 0.12M | 0.16M | 0.71M | 2.30M | 2.67M | 4.32M | 4.71M | 2.27M | 7.46M | 6.60M | 6.77M | 4.59M | 6.38M | 6.21M | 7.08M | 7.67M | 7.77M | 9.05M |
| Accumulated Expenses | 0.14M | 0.29M | 1.16M | 1.69M | 1.91M | 0.47M | 0.37M | 0.34M | 0.36M | 0.50M | 0.49M | ||||||||
| Other Accumulated Expenses | 0.03M | 0.03M | 0.03M | 0.59M | 0.28M | 0.14M | 0.09M | 692.00 | 692.00 | 692.00 | |||||||||
| Current Leases | 0.34M | 0.20M | 0.01M | ||||||||||||||||
| Current Taxes | 0.06M | 0.60M | 0.60M | 0.07M | 0.03M | 0.02M | 0.08M | 0.09M | 0.08M | 0.08M | 0.08M | 0.08M | |||||||
| Total Current Liabilities | 0.10M | 0.17M | 0.23M | 0.88M | 30.75M | 3.29M | 4.41M | 4.80M | 3.51M | 11.65M | 8.78M | 9.42M | 7.40M | 7.86M | 7.62M | 8.45M | 9.09M | 11.33M | 32.41M |
| Non-Current Liabilities | |||||||||||||||||||
| Convertible Debt | 0.14M | ||||||||||||||||||
| Non-Current Deffered Revenue | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | ||||||||||
| Preferred Stock Liabilities | 178.50M | 178.50M | 178.50M | 179.48M | 13.47M | 13.57M | 13.84M | 8.29M | 8.44M | 14.97M | |||||||||
| Operating Leases | 1.58M | 1.37M | 1.07M | 0.77M | 0.70M | 0.46M | 0.22M | ||||||||||||
| Other Non-Current Liabilities | 0.61M | 0.32M | 3.10M | 0.20M | 0.03M | 0.02M | 0.02M | 0.02M | 0.90M | ||||||||||
| Total Non-Current Liabilities | 52.76M | 46.86M | -45,707.73M | -38.54M | -39.25M | 8.08M | 8.43M | 9.07M | 10.57M | ||||||||||
| Total Liabilities | 187.75M | 187.82M | 187.88M | 189.51M | 53.37M | 26.01M | 27.40M | 22.24M | 47.18M | -45,704.63M | -38.34M | -39.22M | 8.10M | 8.32M | 7.84M | 8.45M | 9.09M | 11.46M | 32.41M |
| Shareholder's Equity | |||||||||||||||||||
| Total Debt | 0.65M | 0.65M | 1.18M | 1.40M | 0.60M | 0.40M | 0.25M | 0.10M | 0.75M | ||||||||||
| Common Equity | -7.67M | -8.05M | -8.16M | -9.06M | -11.00M | -11.58M | -13.29M | -13.77M | -42.06M | 45,713.69M | 45.71M | 45.71M | -1.89M | -0.33M | -1.63M | -4.54M | -5.45M | -9.26M | -30.51M |
| Liabilities and Shareholders Equity | 180.08M | 179.78M | 179.72M | 180.45M | 42.37M | 14.43M | 14.11M | 8.47M | 5.13M | 9.05M | 7.37M | 6.49M | 6.21M | 7.99M | 6.20M | 3.91M | 3.64M | 2.21M | 1.90M |
| Retained Earnings | -11.00M | -13.29M | -13.77M | -43.09M | -64.91M | -67.36M | -71.59M | -70.92M | -76.02M | -81.44M | -86.30M | -90.84M | -96.72M | -97.80M | |||||
| Preferred Shares | 9.44M | 9.44M | 3.58M | 3.18M | 2.43M | 500,000.00M | 8.70M | 7.26M | 7.22M | 14.97M |
Pull Cero Therapeutics Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CERO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CERO", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CERO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();